Osimertinib is a targeted therapy medication primarily used in the treatment of non-small cell lung cancer (NSCLC) harboring specific mutations in the epidermal growth factor receptor (EGFR). Its cost can vary based on factors such as brand, dosage, and regional pricing strategies. Below is a detailed overview of osimertinib, including its indications, pharmacology, dosage, side […]